Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sreekumar U Aiswarya"'
Autor:
Nair Hariprasad Haritha, Akbar Nawab, Vinod Vijayakurup, Nikhil Ponnoor Anto, Vijayasteltar B. Liju, Vijai V. Alex, Areekkara Nisthul Amrutha, Sreekumar U. Aiswarya, Mundanattu Swetha, Balachandran S. Vinod, Sankar Sundaram, Maria V. Guijarro, Thomas Herlevich, Archana Krishna, Nesteena K. Nestory, Smitha V. Bava, Chittalakkottu Sadasivan, Maria Zajac-Kaye, Ruby John Anto
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/03051782caec4638a50ea5fd81a0666a
Autor:
Faisal M. Athikkavil, Sreekumar U. Aiswarya, Remya Johny, Meghna Sudhesh, Amrutha A. Nisthul, Ravi S. Lankalapalli, Ruby J. Anto, Smitha V. Bava
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 2, Pp 227-239 (2023)
Aim: This study was designed to investigate the anticancer efficacy of the organic leaf extracts of the plant, Plectranthus vettiveroides (P. vettiveroides), and to analyze the molecular mechanism of the anticancer activity. Methods: The leaf extrac
Externí odkaz:
https://doaj.org/article/fd25c011818c42dd9335a8d337684004
Autor:
Mohan Shankar Gopinatha Pillai, Sreekumar U. Aiswarya, Chenicheri K. Keerthana, Tennyson P. Rayginia, Ruby John Anto
Publikováno v:
iScience, Vol 26, Iss 6, Pp 106816- (2023)
Summary: Non-melanoma skin cancer (NMSC) is the most frequently diagnosed cancer worldwide. Among the various types of NMSCs, cutaneous squamous cell carcinoma (cSCC) exhibits more aggressive phenotype and is also the second-most prevalent type. Rece
Externí odkaz:
https://doaj.org/article/8901981779b24f8cbc12ced47777951a
Autor:
Lekshmi R. Nath, Mundanattu Swetha, Vinod Vijayakurup, Arun Kumar Thangarasu, Nair Hariprasad Haritha, Anwar Shabna, Sreekumar U. Aiswarya, Tennyson P. Rayginia, C. K. Keerthana, Kalishwaralal Kalimuthu, Sankar Sundaram, Ravi Shankar Lankalapalli, Sreekumar Pillai, Rheal Towner, Noah Isakov, Ruby John Anto
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/1bfc53b0810545caae9783c41132c2c9
Autor:
Lekshmi R. Nath, Mundanattu Swetha, Vinod Vijayakurup, Arun Kumar Thangarasu, Nair Hariprasad Haritha, Anwar Shabna, Sreekumar U. Aiswarya, Tennyson P. Rayginia, C. K. Keerthana, Kalishwaralal Kalimuthu, Sankar Sundaram, Ravi Shankar Lankalapalli, Sreekumar Pillai, Rheal Towner, Noah Isakov, Ruby John Anto
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Our previous study has demonstrated that Uttroside B (Utt-B), a saponin isolated from the leaves of Solanum nigrum Linn induces apoptosis in hepatic cancer cells and exhibits a remarkable growth inhibition of Hepatocellular Carcinoma (HCC). Our innov
Externí odkaz:
https://doaj.org/article/27412c60fb1542d8b30f7778ed53e63b
Autor:
Nair Hariprasad Haritha, Akbar Nawab, Vinod Vijayakurup, Nikhil Ponnoor Anto, Vijayasteltar B. Liju, Vijai V. Alex, Areekkara Nisthul Amrutha, Sreekumar U. Aiswarya, Mundanattu Swetha, Balachandran S. Vinod, Sankar Sundaram, Maria V. Guijarro, Thomas Herlevich, Archana Krishna, Nesteena K. Nestory, Smitha V. Bava, Chittalakkottu Sadasivan, Maria Zajac-Kaye, Ruby John Anto
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe ongoing treatment modalities for breast cancer (BC) primarily rely on the expression status of ER, PR and HER-2 receptors in BC tissues. Our strategy of chemosensitization provides new insights to counter chemoresistance, a major obstac
Externí odkaz:
https://doaj.org/article/98aa0d851ca44ca187bf9bcc4a9ba983
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma
Autor:
Mundanattu Swetha, Chenicheri K. Keerthana, Tennyson P. Rayginia, Lekshmi R. Nath, Nair Hariprasad Haritha, Anwar Shabna, Kalishwaralal Kalimuthu, Arun K. Thangarasu, Sreekumar U. Aiswarya, Somaraj Jannet, Sreekumar Pillai, Kuzhuvelil B. Harikumar, Sankar Sundaram, Nikhil Ponnoor Anto, Dee H. Wu, Ravi S. Lankalapalli, Rheal Towner, Noah Isakov, Sathyaseelan S. Deepa, Ruby John Anto
Publikováno v:
Pharmaceuticals, Vol 15, Iss 5, p 636 (2022)
We previously reported the remarkable potency of uttroside B (Utt-B), saponin-isolated and characterized in our lab from Solanum nigrum Linn, against HCC. Recently, the U.S. FDA approved Utt-B as an ‘orphan drug’ against HCC. The current study va
Externí odkaz:
https://doaj.org/article/b186c71c587e4df097a4a4b437a83fd0
Autor:
Lekshmi R Nath, Vijai V Alex, Sreekumar U Aiswarya, Tennyson P Rayginia, Nair Hariprasad Haritha, Chenicheri K Keerthana, Arun Kumar T Thulasidasan, Mundanattu Swetha, Ravi Shankar Lankalapalli, Ruby John Anto
Despite the advancement in HPV prevention strategies, cervical cancer is a leading cause of cancer death in women worldwide. The anticancer potential of kaempferide, which was derived from Chromolaena odorata, was previously revealed in our in-vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06dc228367f0a9bb4e0514651b7727e5
https://doi.org/10.1101/2023.05.19.541414
https://doi.org/10.1101/2023.05.19.541414
Autor:
Anwar Shabna, Jayesh Antony, Vinod Vijayakurup, Minakshi Saikia, Vijayasteltar B. Liju, Archana P. Retnakumari, Nisthul A. Amrutha, Vijai V. Alex, Mundanattu Swetha, Sreekumar U. Aiswarya, Somaraj Jannet, Uma Subramanian Unni, Sankar Sundaram, Daisy R. Sherin, Nikhil Ponnoor Anto, Smitha V. Bava, Sadasivan Chittalakkottu, Sophia Ran, Ruby John Anto
Publikováno v:
Cellular and molecular life sciences : CMLS. 79(9)
Melanoma is the most aggressive among all types of skin cancers. The current strategies against melanoma utilize BRAF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f9fa9b0d8c2b5a46ab9c23be53e2dec
https://pubmed.ncbi.nlm.nih.gov/35948813
https://pubmed.ncbi.nlm.nih.gov/35948813
Autor:
Sreekumar U Aiswarya, Smitha V. Bava, Archana Krishna, Nikhil Ponnoor Anto, Mundanattu Swetha, Nair Hariprasad Haritha, Maria V. Guijarro, Chittalakkottu Sadasivan, Sankar Sundaram, Vinod Vijayakurup, Nesteena K Nestory, Maria Zajac-Kaye, Vijai V. Alex, Vijayasteltar Belsamma Liju, Akbar Nawab, Areekkara Nisthul Amrutha, Thomas Herlevich, Ruby John Anto, Balachandran S Vinod
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundThe ongoing treatment modalities for breast cancer (BC) primarily rely on the expression status of ER, PR and HER-2 receptors in BC tissues. Our strategy of chemosensitization provides new insights to counter chemoresistance, a major obstac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b465c2ad63272715e5bec56fee54ea47
https://www.frontiersin.org/articles/10.3389/fonc.2021.656804/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.656804/full